]>
IRCT20201221049780N1 IRCT 2021-03-17 Mashhad University of Medical Sciences Efficacy of Photodynamic therapy with topical Indocyanine green in the treatment of Keloidal lesions Efficacy of Photodynamic therapy with topical Indocyanine green in the treatment of Keloidal lesions 2021-04-21 anticipated 15 Complete https://irct.ir/trial/53240 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2 keloid. Intervention group: patients under treatment with indocyanine green 0.2% ointment and photodynamic therapy after 1 hour, every 2 weeks for total of 6 sessions. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is no further information is available
public Sara Fakhraei
Imam Reza Hospital, Imam Reza Square, Mashhad
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 3802 2031 fakhraeis971@mums.ac.ir Mashhad University of Medical Sciences scientific Ahmadreza Taheri Bojd
Faculty of Medicine, Pardis Campus, Azadi Square, Mashhad
Mashhad Iran (Islamic Republic of) 9177948564 +98 51 3800 2000 taheriar@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) the patients are selected based on dermatologist diagnosis as having idiopathic keloids minimum age for being selected is 18 years old patients have no history of any medical treatments for their lesions at least in 3 months lesions are on trunk, extremities, back and buttock 18 years no limit Both any skin disease or abnormality around the lesion for example dermatitis, bacterial or fungal infections pregnancy lactation lesions on face and genitalia history of any medical treatments for their lesions in 3 last months L91.0 Hypertrophic scar Treatment - Drugs Intervention group: patients under treatment with indocyanine green 0.2% ointment and photodynamic therapy after 1 hour, every 2 weeks for total of 6 sessions Improvement of keloidal lesions based on POSAS score. Timepoint: before the trial, every month after starting trial, in 6th and 12th weeks after finishing the trial. Method of measurement: Patient and Observer Scar Assessment Scale. Mashhad University of Medical Sciences Approved 2020-12-21 Ethics committee of Mashhad University of Medical Sciences Central Building of Mashhad University of Medical Sciences (Ghorshi), Daneshgah 16, Daneshgah street Mashhad Razavi Khorasan Iran (Islamic Republic of)